Search Results - "Koychev, D."
-
1
Pertuzumab (P) as ≥ second-line therapy for HER2-positive metastatic breast cancer (mBC): Swiss clinical experience
Published in Annals of oncology (01-05-2019)Get full text
Journal Article -
2
ZM447439, a novel promising aurora kinase inhibitor, provokes antiproliferative and proapoptotic effects alone and in combination with bio- and chemotherapeutic agents in gastroenteropancreatic neuroendocrine tumor cell lines
Published in Neuroendocrinology (01-01-2010)“…Therapeutic approaches to gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still not satisfactory. A new direction in treatment options could be the…”
Get more information
Journal Article -
3
Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update
Published in International journal of andrology (01-08-2011)“…Summary Since the introduction of cisplatin‐based therapy in the late 1970s, germ cell tumours (GCT) have been one of the successes in oncology with high cure…”
Get full text
Journal Article -
4
Behandlung von Patienten mit cisplatinrefraktären Keimzelltumoren
Published in Der Onkologe (01-07-2013)“…Zusammenfassung Hintergrund Seit Einführung von Cisplatin in die Behandlung der Keimzelltumoren (KZT) gelten diese als eine Modellerkrankung für einen…”
Get full text
Journal Article -
5
177PPertuzumab (P) as ≥ second-line therapy for HER2-positive metastatic breast cancer (mBC): Swiss clinical experience
Published in Annals of oncology (01-05-2019)Get full text
Journal Article -
6
Aurora kinases as novel drug targets in gastroenteropancreatic neuroendocrine tumor disease: Antiproliferative and pro-apoptotic effects of ZM 447439, a new aurora kinase inhibitor, in BON and QGP-1 cells
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article